Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2021-09-01 Sale |
2021-09-01 9:00 pm |
Adaptimmune Therapeutics PLC | ADAP | Rawcliffe Adrian Chief Executive Officer |
2,782 | $5.195 | $14,452 | 3,070 (Direct) |
View |
| 2021-08-02 Sale |
2021-08-02 5:09 pm |
Adaptimmune Therapeutics PLC | ADAP | Lunger John Chief Patient Supply Officer |
2,939 | $3.5848 | $10,536 | 4,873 (Direct) |
View |
| 2021-07-02 Sale |
2021-07-02 8:01 pm |
Adaptimmune Therapeutics PLC | ADAP | Bertrand William C JR Chief Operating Officer |
4,375 | $4.2649 | $18,659 | 7,329 (Direct) |
View |
| 2021-07-02 Sale |
2021-07-02 8:01 pm |
Adaptimmune Therapeutics PLC | ADAP | Lunger John Chief Patient Supply Officer |
1,907 | $4.2649 | $8,133 | 3,170 (Direct) |
View |
| 2021-06-28 Sale |
2021-06-28 9:01 pm |
Adaptimmune Therapeutics PLC | ADAP | Rawcliffe Adrian Chief Executive Officer |
2,794 | $4.37 | $12,210 | 3,058 (Direct) |
View |
| 2021-06-01 Purchase |
2021-06-03 4:31 pm |
Adaptimmune Therapeutics PLC | ADAP | Alleva Lawrence M Director |
12,600 | $0.79 | $9,954 | 143,364 (Indirect Direct) |
View |
| 2021-01-19 Sale |
2021-01-19 9:01 pm |
Adaptimmune Therapeutics PLC | ADAP | Norry Elliot Chief Medical Officer |
2,111 | $5.6695 | $11,968 | 3,539 (Direct) |
View |
| 2021-01-19 Sale |
2021-01-19 9:01 pm |
Adaptimmune Therapeutics PLC | ADAP | Lunger John Chief Patient Supply Officer |
4,358 | $5.6695 | $24,708 | 7,346 (Direct) |
View |
| 2021-01-19 Sale |
2021-01-19 9:00 pm |
Adaptimmune Therapeutics PLC | ADAP | Rawcliffe Adrian Chief Executive Officer |
9,879 | $5.6695 | $56,009 | 13,529 (Direct) |
View |
| 2021-01-12 Sale |
2021-01-12 9:01 pm |
Adaptimmune Therapeutics PLC | ADAP | Bertrand William C JR Chief Operating Officer |
2,234 | $6.1522 | $13,744 | 3,768 (Direct) |
View |
| 2021-01-12 Sale |
2021-01-12 9:01 pm |
Adaptimmune Therapeutics PLC | ADAP | Lunger John Chief Patient Supply Officer |
1,058 | $6.1522 | $6,509 | 1,767 (Direct) |
View |
| 2021-01-12 Sale |
2021-01-12 9:00 pm |
Adaptimmune Therapeutics PLC | ADAP | Norry Elliot Chief Medical Officer |
841 | $6.1522 | $5,174 | 1,396 (Direct) |
View |
| 2021-01-12 Sale |
2021-01-12 9:00 pm |
Adaptimmune Therapeutics PLC | ADAP | Rawcliffe Adrian Chief Executive Officer |
2,707 | $6.1522 | $16,654 | 3,695 (Direct) |
View |
| 2021-01-04 Sale |
2021-01-05 9:02 pm |
Adaptimmune Therapeutics PLC | ADAP | Lunger John Chief Patient Supply Officer |
1,065 | $5.3279 | $5,674 | 1,760 (Direct) |
View |
| 2021-01-04 Sale |
2021-01-05 9:01 pm |
Adaptimmune Therapeutics PLC | ADAP | Bertrand William C JR Chief Operating Officer |
3,499 | $5.3279 | $18,642 | 5,864 (Direct) |
View |
| 2021-01-04 Sale |
2021-01-05 9:00 pm |
Adaptimmune Therapeutics PLC | ADAP | Norry Elliot Chief Medical Officer |
845 | $5.3279 | $4,502 | 1,392 (Direct) |
View |
| 2021-01-04 Sale |
2021-01-05 9:00 pm |
Adaptimmune Therapeutics PLC | ADAP | Rawcliffe Adrian Chief Executive Officer |
4,967 | $5.3279 | $26,464 | 6,737 (Direct) |
View |
| 2020-12-14 Purchase |
2020-12-16 9:00 pm |
Adaptimmune Therapeutics PLC | ADAP | Wood Gavin Chief Financial Officer |
24,000 | $0.6896 | $16,550 | 57,000 (Direct) |
View |
| 2020-12-14 Purchase |
2020-12-15 9:00 pm |
Adaptimmune Therapeutics PLC | ADAP | Bertrand William C JR Chief Operating Officer |
207,000 | $0.6948 | $143,824 | 284,808 (Direct) |
View |
| 2020-09-01 Sale |
2020-09-02 9:00 pm |
Adaptimmune Therapeutics PLC | ADAP | Rawcliffe Adrian Chief Executive Officer |
2,776 | $8.5149 | $23,637 | 3,076 (Direct) |
View |
| 2020-08-03 Sale |
2020-08-04 9:02 pm |
Adaptimmune Therapeutics PLC | ADAP | Lunger John Chief Patient Supply Officer |
4,823 | $9.25 | $44,613 | 8,066 (Direct) |
View |
| 2020-08-03 Sale |
2020-08-04 9:01 pm |
Adaptimmune Therapeutics PLC | ADAP | Rawcliffe Adrian Chief Executive Officer |
2,788 | $9.25 | $25,789 | 3,064 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2021-07-01 Option Award |
2021-07-02 5:03 pm |
2022-07-01 2031-07-01 |
Adaptimmune Therapeutics PLC | ADAP | Zaks Tal Zvi Director |
379,788 | $0 | 379,788 (Direct) |
View |
| 2021-07-01 Option Award |
2021-07-02 5:03 pm |
2022-07-01 2031-07-01 |
Adaptimmune Therapeutics PLC | ADAP | Alleva Lawrence M Director |
505,918 | $0 | 505,918 (Direct) |
View |
| 2021-07-01 Option Award |
2021-07-02 5:03 pm |
2022-07-01 2031-07-01 |
Adaptimmune Therapeutics PLC | ADAP | Furey John Director |
379,788 | $0 | 379,788 (Direct) |
View |
| 2021-07-01 Option Award |
2021-07-02 5:02 pm |
2022-07-01 2031-07-01 |
Adaptimmune Therapeutics PLC | ADAP | Noble James Director |
379,788 | $0 | 379,788 (Direct) |
View |
| 2021-07-01 Option Award |
2021-07-02 5:01 pm |
2022-07-01 2031-07-02 |
Adaptimmune Therapeutics PLC | ADAP | Sigal Charles Elliott Director |
474,385 | $0 | 474,385 (Direct) |
View |
| 2021-07-01 Option Award |
2021-07-02 5:01 pm |
2022-07-01 2031-07-01 |
Adaptimmune Therapeutics PLC | ADAP | MOTT DAVID M Director |
579,494 | $0 | 579,494 (Direct) |
View |
| 2021-07-01 Option Award |
2021-07-02 5:01 pm |
2022-07-01 2031-07-01 |
Adaptimmune Therapeutics PLC | ADAP | Behbahani Ali Director |
474,385 | $0 | 474,385 (Direct) |
View |
| 2021-07-01 Option Award |
2021-07-02 5:00 pm |
2022-07-01 2031-07-01 |
Adaptimmune Therapeutics PLC | ADAP | Duncan Barbara Gayle Director |
379,788 | $0 | 379,788 (Direct) |
View |
| 2021-03-03 Exercise |
2021-03-03 9:01 pm |
N/A N/A |
Adaptimmune Therapeutics PLC | ADAP | TAYTON-MARTIN HELEN KATRINA Chief Business Officer |
1,785,000 | $0.157 | 1,800,000 (Direct) |
View |
| 2021-01-11 Option Award |
2021-01-11 9:03 pm |
N/A 2031-01-11 |
Adaptimmune Therapeutics PLC | ADAP | Wood Gavin Chief Financial Officer |
1,329,528 | $0 | 1,329,528 (Direct) |
View |
| 2021-01-11 Option Award |
2021-01-11 9:02 pm |
N/A 2031-01-11 |
Adaptimmune Therapeutics PLC | ADAP | Norry Elliot Chief Medical Officer |
1,329,528 | $0 | 1,329,528 (Direct) |
View |
| 2021-01-11 Option Award |
2021-01-11 9:02 pm |
N/A 2031-01-11 |
Adaptimmune Therapeutics PLC | ADAP | Rawcliffe Adrian Chief Executive Officer |
3,988,560 | $0 | 3,988,560 (Direct) |
View |
| 2021-01-11 Option Award |
2021-01-11 9:01 pm |
N/A 2031-01-11 |
Adaptimmune Therapeutics PLC | ADAP | TAYTON-MARTIN HELEN KATRINA Chief Business Officer |
1,329,528 | $0 | 1,329,528 (Direct) |
View |
| 2021-01-11 Option Award |
2021-01-11 9:00 pm |
N/A 2031-01-11 |
Adaptimmune Therapeutics PLC | ADAP | Lunger John Chief Patient Supply Officer |
1,329,528 | $0 | 1,329,528 (Direct) |
View |
| 2021-01-11 Option Award |
2021-01-11 9:00 pm |
N/A 2031-01-11 |
Adaptimmune Therapeutics PLC | ADAP | Bertrand William C JR Chief Operating Officer |
1,329,528 | $0 | 1,329,528 (Direct) |
View |
| 2020-07-01 Option Award |
2020-07-01 5:13 pm |
2021-07-01 2030-07-01 |
Adaptimmune Therapeutics PLC | ADAP | Behbahani Ali Director |
184,258 | $0 | 184,258 (Direct) |
View |
| 2020-07-01 Option Award |
2020-07-01 5:10 pm |
2021-07-01 2030-07-01 |
Adaptimmune Therapeutics PLC | ADAP | Zaks Tal Zvi Director |
144,000 | $0 | 144,000 (Direct) |
View |